U.S. Senate Special Committee on Aging - Expert Testimony from NOF CEO Elizabeth Thompson

On Wednesday, October 16th at 9:30 AM ET, NOF CEO Elizabeth Thompson provided expert testimony at the U.S. Senate’s Special Committee on Aging. Thompson briefed the Committee on the results of a major new report commissioned by NOF that highlights the public health crisis of osteoporosis. She will testify in support of bipartisan Senate Bill 239, “Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019”, and make other recommendations on measures the Committee can take to improve healthcare outcomes for osteoporosis patients and lower health care costs.

Read More
Andrea Medeiros
A Rare Win For Patients and the System: Addressing America's Bone Health Crisis by NOF CEO Elizabeth Thompson

There is a daily debate in Washington about how to lower U.S. health care costs that often pits increasing patient access against lowering costs to our healthcare system. However, in addressing American’s bone health crisis - where half of Americans age 50 and up are at risk of an osteoporotic fracture at an annual cost of $52 billion to Medicare - policymakers have a unique opportunity to support legislation that both improves patient health and decreases this staggering cost.

Read More
Andrea Medeiros
New Report on Burden of Osteoporosis Highlights Huge and Growing Economic and Human Toll of the Disease

A new report released today by the National Osteoporosis Foundation (NOF) finds that despite the existence of proven preventive measures, approximately 2 million Americans on Medicare suffered 2.3 million osteoporosis-related bone fractures in 2015. These totals mean osteoporotic fractures are responsible for more hospitalizations than heart attacks, strokes and breast cancer combined.

Read More
Andrea Medeiros
New Report Highlights Patient Perception of Value in Treatment of Osteoporosis and Bone Fragility

A new report released today by the National Osteoporosis Foundation (NOF), the nation’s leading health organization dedicated to preventing osteoporosis and broken bones, found that the vast majority of patients, including those at highest risk of a osteoporotic/fragility fracture (i.e., those who have experienced a previous fracture after age 50), remain untreated. The study found that these high-risk patients remain untreated despite knowing of their increased fracture risk, having concerns that a fracture could severely limit quality of life, and being aware of their treatment options.

Read More
Andrea Medeiros